PIDOTIMOD A NEW EFFICIENT PRODUCT IN IMMUNOLOGICAL PROPHYLAXIS AND IMMUNOLOGICAL THERAPY OF RESPIRATORY INFECTIONS IN CHILDREN
<em>The article contains analysis of results of international trial of pidotimod (imunorix) efficiency. pidotimod is a new safe immunomodulator, which is both efficient in prophylactic use and as a medication. At the same time, the drug is capable of intensify the effect of antibiotics and oth...
Saved in:
| Main Author: | |
|---|---|
| Format: | Book |
| Published: |
"Paediatrician" Publishers LLC,
2008-01-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | <em>The article contains analysis of results of international trial of pidotimod (imunorix) efficiency. pidotimod is a new safe immunomodulator, which is both efficient in prophylactic use and as a medication. At the same time, the drug is capable of intensify the effect of antibiotics and other medications. This fact is confirmed by the results of controlled trials with participation of a large number of patients. pidotimod is ministerial to a faster disappearance of signs and symptoms of infection, anticipating the recovery with reduced administration of associated drugs.</em><br /><strong><em>Key words: pidotimod, immunomodulator, acute respiratory infections, prophylaxis, treatment.</em></strong> |
|---|---|
| Item Description: | 1682-5527 1682-5535 |